Picard Announces Appointment of Two New Members to its Board of Directors

Core Insights - Picard Medical, Inc. has strengthened its Board of Directors by appointing Sam Van and George Ye, who bring extensive expertise in capital markets and medical technology [1][2][3] Group 1: Board Appointments - Sam Van has a strong background in financial and capital markets, having held senior positions at Freedom U.S. Markets and the New York Stock Exchange, where he was involved in over 60 new listings [2][3] - George Ye has extensive experience in the medical device industry, having served in senior roles at Edwards Lifesciences and previously at Abbott Laboratories and Johnson & Johnson [3] Group 2: Company Overview - Picard Medical, Inc. is the parent company of SynCardia Systems, which is known for its SynCardia Total Artificial Heart, the only commercially available total artificial heart technology in the U.S. and Canada [4] - The SynCardia Total Artificial Heart has been implanted over 2,100 times across 27 countries, making it the most widely used artificial heart globally [4]